Skip to main content
. Author manuscript; available in PMC: 2024 Mar 13.
Published in final edited form as: Atherosclerosis. 2023 May 18;376:11–18. doi: 10.1016/j.atherosclerosis.2023.05.013

Table 2.

Differences in OCT measurements between plaque erosion and control groups.

Characteristic Erosion (N = 24) Control (N = 22) p-value
Culprit lesion location <0.0001
Proximal LAD n (%) 7 (29) 10 (45)
Mid/distal LAD n (%) 5 (21) 5 (23)
LCX n (%) 2(8) 4 (18)
RCA n (%) 10 (42) 3 (14)
Lesion length (mm) 15.3 ± 5.8 15.2 ± 4.8 0.98
Minimal lumen area (mm2) 1.7 ± 0.5 2.0 ± 0.6 0.08
Reference lumen area (mm2) 7.8 ± 1.9 8.0 ± 2.1 0.85
% Lumen area stenosis 77 ± 7 74 ± 8 0.15
Plaque type by quadrant a
Total quadrants at the region of interest 290 ± 49 358 ± 125 0.09
Lipid rich 30.2 ± 16 119.1 ± 74.3 0.001
% of diseased quadrants 15.4 ± 9.9 49.7 ± 24.7 0.001
Fibrous 130.6 ± 47.8 73.9 ± 61.7 0.001
% of diseased quadrants 66.3 ± 39 28.8 ± 17 0.001
Calcified 36 ± 11.3 51.1 ± 58.2 0.11
% of diseased quadrants 18.3 ± 12 21.5 ± 21 0.10
Total diseased quadrants 196.8 ± 61.1 244.1 ± 101.7 0.19
Maximum lipid arc (°) 85.4 ± 48.2 196.5 ± 61.8 0.001
Maximum calcium arc (°) 75.6 ± 70.0 114.3 ± 102.2 0.02
Minimal fibrous cap thickness (μm) 92.3 ± 16 93.1 ± 23.6 0.90
Cholesterol crystals n (%) 9 (37%) 15 (68%) 0.001

Values are presented as mean ± SD for continuous variables and n (%) for categorical variables.

a

Absolute number of quadrants with each plaque type throughout the lesion, measured at 0.2 mm intervals.